506181 Sigma-Aldrichp75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5, acts as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in dorsal root ganglion & postnatal cerebellar neurons.
More>> p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5, acts as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in dorsal root ganglion & postnatal cerebellar neurons. Less<<Synonyms: TAT-Pep5, H-YGRKKRRQRRR-CFFRGGFFNHNPRYC-OH, Cyclic
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Empirical Formula |
|---|
| C₁₅₀H₂₂₇N₅₇O₃₂S₂ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 506181-500UG |
|
Plastic ampoule | 500 μg |
|
— |
| Description | |
|---|---|
| Overview | The p75NTR inhibitor Pep5 (Cat. No. 506180) is made cell-permeable by fusing it with the N-terminal protein transduction domain sequence (11 amino acids) from HIV protein TAT. Shown to act as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in both DRG (dorsal root ganglion) and postnatal cerebellar neurons. A potential therapeutic agent against inhibition of regeneration in the central nervous system. |
| Catalogue Number | 506181 |
| Brand Family | Calbiochem® |
| Synonyms | TAT-Pep5, H-YGRKKRRQRRR-CFFRGGFFNHNPRYC-OH, Cyclic |
| References | |
|---|---|
| References | Yamashita, T., and Tohyama, M. 2003. Nat. Neurosci. 6, 461. Schwarze, S.R., et al. 1999. Science 285, 1569. |
| Product Information | |
|---|---|
| ATP Competitive | N |
| Form | Lyophilized solid |
| Formulation | Supplied as a trifluoroacetate salt. |
| Hill Formula | C₁₅₀H₂₂₇N₅₇O₃₂S₂ |
| Chemical formula | C₁₅₀H₂₂₇N₅₇O₃₂S₂ |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Quality Level | MQ100 |
| Biological Information | |
|---|---|
| Primary Target | Blocker of MAG- and Nogo-induced inhibition of neurite outgrowth |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Peptide Sequence | H₂N-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys¹²-Phe-Phe-Arg-Gly-Gly-Phe-Phe-Asn-His-Asn-Pro-Arg-Tyr-Cys²⁶-OH disulfide bond (12-26) |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 506181-500UG | 04055977272413 |
Documentation
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem SDS
| Title |
|---|
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 506181 |
References
| Reference overview |
|---|
| Yamashita, T., and Tohyama, M. 2003. Nat. Neurosci. 6, 461. Schwarze, S.R., et al. 1999. Science 285, 1569. |



